AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
_6ff029a61766633234293.png?format=webp&width=1186&height=250)
Fulgent Genetics's 15min chart shows a KDJ Golden Cross, bullish Marubozu pattern.
ByAinvest
Monday, Aug 18, 2025 1:49 pm ET1min read
Fulgent Genetics' 15-minute chart has recently exhibited a bullish trend, as evidenced by the KDJ Golden Cross and the formation of a Bullish Marubozu pattern at 08/18/2022 13:45. This shift in momentum suggests a potential upward trajectory for the stock price, with buyers firmly in control of the market. As a result, it is likely that the bullish momentum will continue.
Fulgent Genetics (NASDAQ: FLGT) has shown signs of a bullish trend in its 15-minute chart, with the appearance of a KDJ Golden Cross and a Bullish Marubozu pattern on August 18, 2022, at 13:45. This technical analysis suggests a shift in momentum towards an upward trajectory, with buyers currently dominating the market and bullish momentum anticipated to persist.The KDJ Golden Cross, a technical indicator used to predict trend changes, indicates that the short-term moving average (K) has crossed above the long-term moving average (D). This pattern often signals a bullish trend, suggesting that the stock price may continue to rise. The Bullish Marubozu, characterized by a single candlestick with no lower wick and a long upper wick, further reinforces this bullish sentiment by indicating strong buying pressure.
Despite the recent earnings report for the second quarter of 2025, which showed a 15% year-over-year (YoY) increase in revenue but also a net loss of $19.0 million, the stock price has remained relatively stable. The company's full-year core revenue guidance was raised to $320 million, reflecting strong momentum in its laboratory services and therapeutic development businesses [1].
Looking ahead, Fulgent Genetics has forecasted average revenue growth of 9.0% per annum over the next three years, compared to a 6.0% industry growth forecast for the U.S. healthcare sector [1]. The technical analysis, however, indicates a bullish trend, with a KDJ Golden Cross and a Bullish Marubozu signaling an upward momentum in the stock price [4].
References:
[1] https://finance.yahoo.com/news/fulgent-genetics-second-quarter-2025-131814335.html
[2] https://www.tipranks.com/news/company-announcements/fulgent-genetics-reports-q2-2025-financial-results
[3] https://www.marketbeat.com/instant-alerts/fulgent-genetics-nasdaqflgt-shares-gap-up-after-earnings-beat-2025-08-01/
[4] https://www.investing.com/news/transcripts/earnings-call-transcript-fulgent-genetics-q2-2025-exceeds-revenue-forecast-stock-surges-93CH-4166152
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet